IRIS
LATTANZIO, ROSSANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.328
AS - Asia 3.278
EU - Europa 3.145
Continente sconosciuto - Info sul continente non disponibili 546
SA - Sud America 464
AF - Africa 80
OC - Oceania 14
Totale 12.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.175
SG - Singapore 1.443
IT - Italia 861
CN - Cina 763
IE - Irlanda 436
VN - Vietnam 386
BR - Brasile 377
RU - Federazione Russa 305
SE - Svezia 305
UA - Ucraina 247
GB - Regno Unito 240
DE - Germania 223
TR - Turchia 221
FR - Francia 184
IN - India 135
FI - Finlandia 94
CA - Canada 82
HK - Hong Kong 65
AT - Austria 47
BD - Bangladesh 47
JP - Giappone 38
MX - Messico 36
NL - Olanda 36
PL - Polonia 35
ZA - Sudafrica 35
CZ - Repubblica Ceca 28
AR - Argentina 27
IQ - Iraq 26
BE - Belgio 21
ES - Italia 21
EC - Ecuador 17
PH - Filippine 15
PK - Pakistan 15
AU - Australia 13
ID - Indonesia 13
KR - Corea 13
UZ - Uzbekistan 13
LT - Lituania 12
SA - Arabia Saudita 12
TH - Thailandia 12
CO - Colombia 11
MY - Malesia 11
CH - Svizzera 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
HN - Honduras 7
JM - Giamaica 7
KE - Kenya 7
TN - Tunisia 7
UY - Uruguay 7
VE - Venezuela 7
BG - Bulgaria 6
DZ - Algeria 6
IR - Iran 6
JO - Giordania 6
PT - Portogallo 5
PY - Paraguay 5
RS - Serbia 5
AO - Angola 4
BO - Bolivia 4
CL - Cile 4
CR - Costa Rica 4
DK - Danimarca 4
MO - Macao, regione amministrativa speciale della Cina 4
RO - Romania 4
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
GD - Grenada 3
GR - Grecia 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
NG - Nigeria 3
NI - Nicaragua 3
SR - Suriname 3
TT - Trinidad e Tobago 3
CU - Cuba 2
DO - Repubblica Dominicana 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
Totale 12.305
Salva come PNG Salva come JPEG
Città #
Singapore 1.100
San Jose 616
Chandler 498
Dublin 427
Ashburn 423
Jacksonville 328
Beijing 226
Council Bluffs 222
Santa Clara 164
Dallas 163
Princeton 160
Los Angeles 153
Ho Chi Minh City 142
New York 127
Southend 124
Pescara 115
Dearborn 112
The Dalles 111
Chieti 104
Izmir 102
Nanjing 96
Ann Arbor 78
Hanoi 74
Wilmington 74
Altamura 73
Hong Kong 58
Munich 55
Boardman 54
Cambridge 50
Orem 45
Tongling 42
Moscow 41
São Paulo 41
Rome 40
Redondo Beach 39
Collecorvino 36
Columbus 34
Dong Ket 34
Denver 33
Vienna 33
Milan 32
Nanchang 31
London 29
Chicago 28
Houston 28
Phoenix 28
Washington 28
Buffalo 27
Johannesburg 27
Montreal 27
Shenyang 27
Tokyo 27
Atlanta 26
Brooklyn 25
Woodbridge 24
Warsaw 23
Frankfurt am Main 21
Hebei 21
Hefei 21
Turku 21
Ancona 20
Chennai 20
Brussels 18
Seattle 18
Stockholm 18
Amsterdam 17
Brno 17
Catania 17
Nuremberg 17
Tianjin 17
Helsinki 16
Jiaxing 16
Boston 15
Da Nang 15
Lappeenranta 15
San Vito Chietino 15
Ankara 13
Bologna 13
Haiphong 13
Mumbai 13
Poplar 13
Rio de Janeiro 13
St Louis 13
Grevenbroich 12
Jinan 12
Manchester 12
Messina 12
Mexico City 12
Seoul 11
Toronto 11
Kunming 10
San Francisco 10
Tashkent 10
Bangkok 9
Shanghai 9
Biên Hòa 8
Charlotte 8
Guayaquil 8
Macerata 8
Medford 8
Totale 7.500
Salva come PNG Salva come JPEG
Nome #
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 260
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 247
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 237
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 222
A unique four-hub protein cluster associates to glioblastoma progression 221
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 210
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 210
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 196
Trop-2 is a determinant of breast cancer survival. 192
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 175
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 175
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 173
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 173
Upregulation of Trop-2 quantitatively stimulates human cancer growth 168
ABCC3 is a novel target for the treatment of pancreatic cancer 168
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 167
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 163
Exosomes as pleiotropic players in pancreatic cancer 161
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 160
The Trop-2 signalling network in cancer growth 160
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 160
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 160
Prognostic relevance of LGALS3BP in human colorectal carcinoma 160
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 158
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 157
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 156
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 154
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 154
Molecular studies of pulmonary carcinoids 153
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 149
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 148
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 148
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 147
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 146
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 144
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 140
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 139
[Tissue microarrays] 138
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 137
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 137
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 136
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 136
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 135
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 132
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 132
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 132
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 131
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 131
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 131
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 129
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 128
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 128
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 125
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 125
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 121
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 120
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 119
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 119
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 118
Pioneers in Pathology 116
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 115
Role of phospholipase C in cell invasion and metastasis 115
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 115
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 114
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 113
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 113
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 113
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 113
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 111
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 111
Phospholipase Cgamma1 is required for metastasis development and progression 111
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 108
Loss of primary cilia promotes inflammation and carcinogenesis 105
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 104
The role of phospholipase Cγ1 in breast cancer and its clinical significance 103
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 103
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 101
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 98
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 95
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 95
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 94
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 89
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 89
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 88
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 88
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 84
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 82
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 78
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 76
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 74
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 72
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 67
Novel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report 62
null 57
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 51
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 47
null 41
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 33
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 27
null 21
Totale 12.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022488 0 0 25 126 14 47 10 24 31 22 64 125
2022/20231.337 104 236 78 135 138 219 69 121 138 17 42 40
2023/2024908 52 28 67 38 52 288 175 42 25 31 12 98
2024/20252.347 89 439 375 88 76 114 161 146 241 144 227 247
2025/20264.577 357 171 363 629 517 284 740 262 450 417 272 115
2026/2027505 93 367 45 0 0 0 0 0 0 0 0 0
Totale 12.855